このページを印刷する このページを印刷する
Paras Biopharmaceuticals
ブース番号 V-24 パビリオン
住所 Kiviharjunlenkki 10, OULU, FI-90220
TEL +358-442-709-462
URL http://www.parasbiopharma.com
Email mark.jackson@parasbiopharma.com
出展品目 Forteo Biosimilar
Anakinra Biosimilar
Recombinant Enterokinase
TEV Protease
Romiplostim (N-plate) & Insulin Aspart
ロゴ・写真
見どころ Paras Biopharmaceuticals is one of two companies worldwide, who has developed a biosimilar Osteoporosis product of Eli Lilly, (Forteo), which sells 1.4 billion dollars per year. In the Finland facility, we can produce the product for worldwide needs.

We have a full-scale, state-of-the-art, world-class, biologic production set up in Finland. We have four main products in the pipeline. Osteoporosis (biosmilar Forteo), Diabetes (GLP-1) and Oncology (new molecule) are the main products.